It is a trading private limited company based in New Delhi, Delhi, India, established in 2011.
2011 | New Delhi, Delhi, India | ActiveExide Healthcare Pharmaceuticals Private Limited, a active private limited company, was established on 23 June 2011 in New Delhi, Delhi, India. Engaging in other wholesale within the trading sector, it holds CIN: U24232DL2011PTC221346. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Jagdish Kumar (Director), Dipika (Director). Past directors included Pradeep Kumar Mishra. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. 90-91, Telephone Exchange Road Near M.T.N.L. Telephone Exchange, Samalk, Ha, New Delhi, Delhi, 110037.
U24232DL2011PTC221346
221346
23 June 2011
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Exide Healthcare Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jagdish Kumar | Director | 23 Jun 2011 | Current |
| Dipika | Director | 30 Sep 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 03 Oct 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Exide Healthcare Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 14.53% increase. The company also saw a substantial fall in profitability, with a 40.7% decrease in profit. The company's net worth moved up by a moderate rise of 5.29%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2015, Exide Healthcare Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Exide Healthcare Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Exide Healthcare Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Exide Healthcare Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Exide Healthcare Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Exide Healthcare Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
Dipika was appointed as a Director was appointed as a Director on 30 Sep 2020 & has been associated with this company since 5 years 2 months . was recorded as a recent event.
Progress on Jagdish Kumar was appointed as a Director was appointed as a Director on 23 Jun 2011 & has been associated with this company since 14 years 5 months . was documented.
Exide Healthcare Pharmaceuticals Private Limited was registered on 23 Jun 2011 with Roc Delhi & aged 14 years 5 months as per MCA records. was recorded as a recent event.
The CIN of Exide Healthcare Pharmaceuticals Private Limited is U24232DL2011PTC221346.
Exide Healthcare Pharmaceuticals Private Limited is headquartered at Plot No. 90-91, Telephone Exchange Road Near M.T.N.L. Telephone Exchange, Samalk, Ha, New Delhi, Delhi, 110037.
Exide Healthcare Pharmaceuticals Private Limited was incorporated on 23 June 2011.
The current directors of Exide Healthcare Pharmaceuticals Private Limited are
The primary industry of Exide Healthcare Pharmaceuticals Private Limited is Trading.
Exide Healthcare Pharmaceuticals Private Limited is unlisted.
The authorized capital of Exide Healthcare Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Exide Healthcare Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX